Fortitude Family Office’s CorMedix CRMD Stock Holding History

Fortitude Family Office’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$470	Hold	61	–	–	﹤0.01%	2418
2026 Q2	$479	Buy	+61	New	+$482	﹤0.01%	1990

Other funds holding CRMD

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

TCOT

Trust Company of Toledo Holland, Ohio $1.25B AUM 28.18% 1-Year Est. Return

Fortitude Family Office's CRMD Position: Q3 2026 in Review

Fortitude Family Office held its CorMedix (CRMD) position steady in Q3 2026 at 61 shares worth $470. The position accounts for ﹤0.01% of the portfolio, ranked #2418.

Fortitude Family Office first reported a position in CRMD in Q2 2026 and has held it in 2 quarters since. The position peaked at $479 in Q2 2026. 10 funds tracked by Wall St. Rank hold CRMD as of Q3 2026.

Fortitude Family Office held 61 shares of CorMedix worth $470 as of Q3 2026.
Fortitude Family Office left its CorMedix share count unchanged in Q3 2026.
CorMedix made up ﹤0.01% of Fortitude Family Office's portfolio in Q3 2026, its #2418 holding.
Fortitude Family Office first reported a position in CorMedix in Q2 2026 and has held it in 2 quarters since.
Fortitude Family Office's CorMedix position peaked at $479 in Q2 2026.
10 funds tracked by Wall St. Rank held CorMedix as of Q3 2026.

Based on Fortitude Family Office's 13F filing for Q3 2026, filed 14 Oct 2026.